Search Results

Medtronic’s Chameleon PTA Balloon Catheter Studied for Single-Device Thrombectomy Interventions

June 23, 2021—Online in The Journal of Vascular Access (JVA), Ari Kramer, MD; John Ross, MD; and Antonios P. Gasparis, MD, reported findings from a novel technique using a single device, the Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter (Medtronic), to safely and efficiently perform percutaneous thrombectomy interventions.

Healionics’ Stargraft Arteriovenous Graft Evaluated in 24-Month Data

November 25, 2025—Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical results for its investigational Stargraft arteriovenous (AV) graft were presented by John Ross, MD, at the CiDA, the Controversies in Dialysis Access symposium.

New 7.5-cm Length Introduced for Gore Viabahn Endoprosthesis

March 1, 2016—Gore & Associates announced the availability of a new 7.5-cm length of the Gore Viabahn endoprosthesis with heparin bioactive surface.

FDA Approves Phraxis EndoForce Connector for Endovascular Venous Anastomosis

May 22, 2025—Phraxis Inc. announced FDA approval of the EndoForce connector for endovascular venous anastomosis for dialysis access in patients with end-stage renal disease.

VentureMed’s Flex Vessel Prep System Receives CMS Transitional Pass-Through Payment

November 8, 2023—VentureMed Group, Inc. announced that the Center for Medicare & Medicaid Services (CMS) has granted the company’s Flex vessel prep (VP) system a transitional pass-through (TPT) payment category a new Healthcare Common Procedure Coding System C-code effective January 1, 2024.

Indication Expanded for AV Medical's Chameleon Balloon Catheter to Include Infusion of Diagnostic or Therapeutic Fluids

February 27, 2017—AV Medical Technologies, Ltd. announced that the company's Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter has received clearance from the US Food and Drug Administration (FDA) for an expanded indication to include infusion of diagnostic or therapeutic fluids.

Fist Assist’s FA-1 Compression Device Studied in FACT for Superficial Arm Vein Dilation

August 4, 2021—Fist Assist Devices, LLC, announced completion of the nonsignificant risk trial, Fist Assist Clinical Trial (FACT).